Diabetes MellitusJohn A. Galloway, Janet H. Potvin, Charles R. Shuman Lilly Research Laboratories, 1988 - 335 pages |
From inside the book
Results 1-3 of 27
Page 182
... CSII from more conven- tional insulin therapy . 23.27.29-32 The number of physicians prescribing and patients using CSII increased dramatically between 1980 and 1982. By late 1982 , an estimated 4,000 to 6,000 CSII pumps had been sold ...
... CSII from more conven- tional insulin therapy . 23.27.29-32 The number of physicians prescribing and patients using CSII increased dramatically between 1980 and 1982. By late 1982 , an estimated 4,000 to 6,000 CSII pumps had been sold ...
Page 188
... CSII , i.e. , preprandial boluses of 0.05 to 0.15 unit / kg of regular insulin are often all that is used ( Figure 10.9 ) . Both physicians and patients have learned that reducing the carbohydrate content of meals can markedly reduce ...
... CSII , i.e. , preprandial boluses of 0.05 to 0.15 unit / kg of regular insulin are often all that is used ( Figure 10.9 ) . Both physicians and patients have learned that reducing the carbohydrate content of meals can markedly reduce ...
Page 190
... CSII in pregnancy . Selecting Patients for Continuous Subcutaneous Insulin Infusion Therapy Candidates for CSII pump therapy should be patients with Type I diabetes who are seriously committed to improving their glycemic control and who ...
... CSII in pregnancy . Selecting Patients for Continuous Subcutaneous Insulin Infusion Therapy Candidates for CSII pump therapy should be patients with Type I diabetes who are seriously committed to improving their glycemic control and who ...
Contents
Definition | 1 |
Chapter 2 iabetes Mellitus and Heredity | 15 |
Chapter 3 athophysiology of Diabetes Mellitus | 27 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities action activity agents antibodies associated betes blood glucose blood glucose concentrations body carbohydrate cause cells changes Chapter clinical complications continuous daily decrease determinations diabetes mellitus diabetic diet diabetic ketoacidosis diagnosis diet disease dose early effect exercise factors Figure given glucose tolerance glycemic glycosylated hemoglobin hormone human insulin hypoglycemia impaired important improved increased indicated individuals initial injection insulin infusion insulin receptor insulin resistance insulin secretion insulin therapy insulin-dependent levels lipoprotein liver meals measure metabolic methods mg/dl mmol/L monitoring muscle myocardial infarction needed normal obese occur oral patients with diabetes patients with Type plasma glucose pregnancy prevent production protein pump receptor reduced regular renal reported response retinopathy risk severe Source studies subcutaneous subjects Table therapy tion tissue treated treatment Type I diabetes Type II units urine usually values weight